Using the same discretized logic, let’s consider LLY stock. In the trailing 10 weeks, the market voted to buy LLY six times ...

GLP-1 receptor agonists like semaglutide and the dual GIP/GLP-1 agonist tirzepatide mimic naturally occurring hormones that regulate blood sugar, appetite, and digestion. GLP-1 (glucagon-like ...

Dr Sharon Viner describes the case a young adult whose age could potentially have delayed investigation for upper ...

Weight loss doesn’t mean you have to give up on taste or stick to bland food. Indian cuisine, when prepared with the right ...

Turku University Hospital will start bariatric surgery, also known as weight loss surgery, for a small number of severely ...

Adolescents who undergo bariatric surgery face a higher risk of weight regain, which can undermine treatment success and long ...

What hits you first is the exhaustion carved into every face. The sickly pallor. The terrifying weight loss ravaging everyone ...

Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

A sweeping analysis of global studies reveals that stopping weight loss drugs, including well-known treatments like Ozempic and Wegovy, often triggers a rapid return of lost pounds.

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...

According to the authors, these findings suggest that losing weight before IVF can raise the total number of pregnancies, ...